EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieOpen Access · CC BY 4.0

Role of IL-2, IL-6, and TNF-α as Potential Biomarkers in Ischemic Heart Disease: A Comparative Study of Patients with CAD and Non-CAD

Ahmed E Altyar iD, Shilpa Bhardwaj, Nehmat Ghaboura iD, Priya Kaushik, Sattam Khulaif Alenezi iD, Mohammed Jaffar Sadiq Mantargi iD, Muhammad Afzal iD

Medical Sciences · 04.04.2025 · 13 (2) · 40

DOI: 10.3390/medsci13020040 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Medical Sciences, online erschienen am 04.04.2025. Verfasst von Ahmed E Altyar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, P.O. Box 80260, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Interleukin-2, Interleukin-6, Tumor Necrosis Factor-alpha, Coronary Artery Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ischemic heart disease (CAD), a leading global health burden, arises primarily from atherosclerosis, an inflammatory condition characterized by lipid accumulation and metabolic dysregulation. The precise contribution of inflammatory cytokines (IL-2, IL-6, and TNF-α) to CAD pathogenesis remains an area of significant research.

Aim

The primary aim of this study is to examine the IL-2, IL-6, and TNF-α in patients with coronary artery disease (CAD) and compare them with Non-CAD individuals to evaluate their potential as diagnostic biomarkers for CAD. Methodology: A prospective observational study was conducted over 3 years, involving 100 participants divided into CAD and non-CAD groups. Blood samples were isolated and analyzed for IL-2, IL-6, and TNF-α levels utilizing ELISA kits. Biochemical parameters, including lipid profiles, were also assessed.

Results

This study observed significantly elevated IL-6 in patients with CAD compared with controls, while IL-2 and TNF-α levels did not reach statistical significance. The CAD group exhibited dyslipidemia characterized by elevated triglycerides and reduced HDL. Furthermore, the CAD group demonstrated alterations in biochemical parameters, including lower albumin and calcium levels, higher urea and uric acid levels, and an elevated erythrocyte sedimentation rate. These findings suggest a systemic inflammatory state and metabolic disturbances in patients with CAD.

Conclusions

This study highlights IL-6 as a potential biomarker and key player in CAD pathogenesis. These findings warrant further investigation into the therapeutic potential of targeting inflammatory pathways for cardiovascular risk reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-2Interleukin-6Tumor Necrosis Factor-alphaCoronary Artery DiseaseMyocardial IschemiaHumansBiomarkersMaleFemaleMiddle AgedAgedProspective Studies

Stichwörter der Autor:innen

coronary artery diseasecytokinesinflammationischemic heart disease

Substanzen

BiomarkersInterleukin-2Interleukin-6Tumor Necrosis Factor-alphaIL2 protein, humanIL6 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, P.O. Box 80260, Jeddah 21589, Saudi Arabia.
  • Pharmacy Program, Department of Pharmacy Practice, Batterjee Medical College, P.O. Box 6231, Jeddah 21442, Saudi Arabia.
  • Department of Neurochemistry, Institute of Human Behaviour and Allied Sciences Hospital, Delhi 110095, India.
  • Pacific Institute of Medical Sciences, Udaipur 313015, India.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
  • Pharmacy Program, Department of Pharmaceutical Sciences, Batterjee Medical College, P.O. Box 6231, Jeddah 21442, Saudi Arabia.

ORCID-Profile: Ahmed E Altyar, Nehmat Ghaboura, Sattam Khulaif Alenezi, Mohammed Jaffar Sadiq Mantargi, Muhammad Afzal

Zitieren

APA

Altyar, A. E., Bhardwaj, S., Ghaboura, N., Kaushik, P., Alenezi, S. K., Mantargi, M. J. S., & Afzal, M. (2025). Role of IL-2, IL-6, and TNF-α as Potential Biomarkers in Ischemic Heart Disease: A Comparative Study of Patients with CAD and Non-CAD. Medical Sciences, 13(2), 40. https://doi.org/10.3390/medsci13020040

Vancouver

Altyar AE, Bhardwaj S, Ghaboura N, Kaushik P, Alenezi SK, Mantargi MJS, et al. Role of IL-2, IL-6, and TNF-α as Potential Biomarkers in Ischemic Heart Disease: A Comparative Study of Patients with CAD and Non-CAD. Medical Sciences. 2025;13(2):40. doi:10.3390/medsci13020040

BibTeX
@article{Altyar2025,
  author = {Altyar, Ahmed E and Bhardwaj, Shilpa and Ghaboura, Nehmat and Kaushik, Priya and Alenezi, Sattam Khulaif and Mantargi, Mohammed Jaffar Sadiq and Afzal, Muhammad},
  title = {Role of IL-2, IL-6, and TNF-α as Potential Biomarkers in Ischemic Heart Disease: A Comparative Study of Patients with CAD and Non-CAD},
  journal = {Medical Sciences},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {40},
  doi = {10.3390/medsci13020040}
}
Kostenlos starten →